You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 534 Responses to immunotherapy based on programmed death-ligand 1 (PD-L1) copy number variation (CNV) status in patients with advanced non-small cell lung cancer (NSCLC)

Alerts

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
534 Responses to immunotherapy based on programmed death-ligand 1 (PD-L1) copy number variation (CNV) status in patients with advanced non-small cell lung cancer (NSCLC)
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address